Viemed Healthcare Balance Sheet Health
Financial Health criteria checks 6/6
Viemed Healthcare has a total shareholder equity of $126.8M and total debt of $4.5M, which brings its debt-to-equity ratio to 3.5%. Its total assets and total liabilities are $169.5M and $42.7M respectively. Viemed Healthcare's EBIT is $17.5M making its interest coverage ratio 19.8. It has cash and short-term investments of $11.3M.
Key information
3.5%
Debt to equity ratio
US$4.46m
Debt
Interest coverage ratio | 19.8x |
Cash | US$11.35m |
Equity | US$126.80m |
Total liabilities | US$42.73m |
Total assets | US$169.53m |
Recent financial health updates
Recent updates
When Should You Buy Viemed Healthcare, Inc. (NASDAQ:VMD)?
Apr 11These 4 Measures Indicate That Viemed Healthcare (NASDAQ:VMD) Is Using Debt Safely
Mar 07Viemed Healthcare: Comments On Q2 Earnings
Aug 25Viemed Healthcare Q2 2022 Earnings Preview
Aug 02Viemed Healthcare: New Bullish Trend Has Just Begun
Dec 29Viemed Healthcare, Inc. 2021 Q1 - Results - Earnings Call Presentation
May 06Viemed Healthcare EPS misses by $0.01, revenue in-line
May 03Strong Execution By Insider-Owners Ensures Viemed's Growth
Jan 11Viemed Healthcare EPS misses by $0.02, beats on revenue
Nov 05Financial Position Analysis
Short Term Liabilities: VMD's short term assets ($47.7M) exceed its short term liabilities ($36.4M).
Long Term Liabilities: VMD's short term assets ($47.7M) exceed its long term liabilities ($6.3M).
Debt to Equity History and Analysis
Debt Level: VMD has more cash than its total debt.
Reducing Debt: VMD's debt to equity ratio has reduced from 23% to 3.5% over the past 5 years.
Debt Coverage: VMD's debt is well covered by operating cash flow (837.9%).
Interest Coverage: VMD's interest payments on its debt are well covered by EBIT (19.8x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/02 04:43 |
End of Day Share Price | 2025/01/02 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Viemed Healthcare, Inc. is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Nick Corcoran | Acumen Capital Finance Partners Limited |
Doug Cooper | Beacon Securities Limited |
Vadim Merkulov | Freedom Broker |